NCT04008784View on ClinicalTrials.gov

Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

July 14, 2020

Study Completion Date

September 8, 2020

Conditions
Atopic Dermatitis
Interventions
DRUG

Crisaborole 2% Topical Application Ointment [EUCRISA]

Ointment

DRUG

Triamcinolone Acetonide 0.1% Ointment

Topical Corticosteroid

Trial Locations (1)

29407

Clinical Research Center of the Carolinas, Charleston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Clinical Research Center of the Carolinas

OTHER